Choroidal neovascularization post macular surgery: a case series

doi:10.18240/ijo.2018.08.28

Cited by 1 publication

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Literature search, in PubMed, revealed six case reports of CNVM after idiopathic ERM peeling and fourteen cases following macular hole surgery. [ 6 7 8 9 10 ] Despite treatment, functional outcome in all these cases was poor. To the best of our knowledge, this is the first reported case of CNVM following retinal detachment surgery with a good visual outcome.…”

Section: Discussionmentioning

confidence: 99%

Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment

Appanraj

Duraiswamy

Saravanan

et al. 2020

Indian J Ophthalmol

View full text Add to dashboard Cite

We report the successful use of intravitreal bevacizumab in the iatrogenic choroidal neovascular membrane (CNVM) following vitreoretinal surgery. A 69-year-old male underwent vitrectomy surgery with silicone oil (SO) tamponade for rhegmatogenous retinal detachment. During fluid air exchange, there was an accidental retinal touch at an area in the papillomacular bundle with the silicone tip cannula. He had persistent subretinal bleed at the area 1 month after surgery. The optical coherence tomography (OCT) showed a subretinal elevated lesion and fluorescein angiography (FFA) showed an active CNVM. The patient was treated with intravitreal bevacizumab in the SO-filled eye. At 1-month postinjection, the OCT revealed reduction in the size of CNVM. The patient underwent SO removal with the second dose of intravitreal bevacizumab. CNVM regressed with no recurrence on follow-up at 1 year. Iatrogenic CNVM is a rare complication following successful vitreoretinal surgery. Prompt diagnosis and treatment with intravitreal bevacizumab may be required for a favorable outcome.

show abstract